|
Delayed
Nasdaq
22:30:04 13/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 2.900 USD | -3.65% |
|
-7.20% | -77.25% |
| 10-29 | Scienture Holdings, Inc. - Shareholder/Analyst Call | |
| 10-13 | Scienture Holdings, Inc. Reports Preliminary, Unaudited Revenue Results for the Third Quarter Ended September 30, 2026 | CI |
| Market Cap | 4.94M 4.47M 4.13M 3.74M 7.05M 465M 7.26M 49.54M 19.69M 248M 18.56M 18.16M 791M | P/E 2026 * |
-0.68x | P/E 2027 * | -11.1x |
|---|---|---|---|---|---|
| Enterprise Value | 4.94M 4.47M 4.13M 3.74M 7.05M 465M 7.26M 49.54M 19.69M 248M 18.56M 18.16M 791M | EV / Sales 2026 * |
1.36x | EV / Sales 2027 * | 0.32x |
| Free-Float |
77.92% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SCNX | Delayed | |
Tradegate
| 4E40 | Real-time | |
|
CBOE
| SCNX | Real-time | |
|
Deutsche Boerse AG
| 4E40 | Delayed |
Last Transcript: Scienture Holdings, Inc.
| 1 day | -3.65% | ||
| 1 week | -7.20% | ||
| Current month | -9.94% | ||
| 1 month | -10.49% | ||
| 3 months | -75.05% | ||
| 6 months | -71.64% | ||
| Current year | -77.25% |
| 1 week | 2.9 |  | 3.23 |
| 1 month | 2.64 | | 3.68 |
| Current year | 2.64 | | 16.11 |
| 1 year | 2.64 | | 18.75 |
| 3 years | 2.64 | | 335.5 |
| 5 years | 2.64 | | 335.5 |
| 10 years | 2.64 | | 335.5 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 19/9/24 | Conversion | Director | 2,927,538 | - | ||
| 19/9/24 | Conversion | Chief Executive Officer | 3,853,296 | - | ||
| 25/7/24 | Other | Director | 57,977 | 4.1225% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.65% | -7.20% | -82.74% | - | 4.94M | |
| +0.35% | +5.35% | +39.46% | +132.82% | 1,271B | |
| +0.86% | +3.49% | +46.41% | +93.64% | 683B | |
| +0.17% | +1.33% | +27.07% | +112.91% | 520B | |
| -0.58% | +3.46% | +39.29% | +69.13% | 389B | |
| -0.68% | -0.37% | +57.30% | +42.66% | 362B | |
| -0.10% | +0.69% | +26.73% | +58.35% | 304B | |
| +0.43% | +0.37% | +3.62% | +36.44% | 286B | |
| -0.62% | +1.02% | +38.43% | +74.40% | 253B | |
| +0.01% | +0.71% | +34.24% | +124.30% | 208B | |
| Average | -0.39% | +1.27% | +22.98% | +82.74% | 428B | |
| Weighted average by Cap. | +0.15% | +2.67% | +36.94% | +95.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.64M 3.29M 3.04M 2.75M 5.19M 342M 5.35M 36.47M 14.49M 183M 13.66M 13.37M 582M | 15.47M 13.99M 12.91M 11.69M 22.06M 1.45B 22.72M 155M 61.6M 778M 58.06M 56.83M 2.47B |
| Net income | -10.43M -9.43M -8.7M -7.88M -14.86M -980M -15.31M -104M -41.51M -524M -39.13M -38.3M -1.67B | -1.26M -1.14M -1.05M -954K -1.8M -119M -1.85M -12.64M -5.02M -63.42M -4.74M -4.64M -202M |
| Net Debt | - | - |
Employees
7
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/11/26 | US$2.900 | -3.65% | 730 |
| 12/11/26 | US$3.010 | -0.99% | 7,218 |
| 11/11/26 | US$3.040 | 0.00% | 6,498 |
| 10/11/26 | US$3.040 | -5.00% | 5,932 |
| 09/11/26 | US$3.200 | +2.40% | 18,404 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3.010USD
Average target price
6.000USD
Spread / Average Target
+99.34%
- Stock Market
- Stocks
- SCNX Stock
Select your edition
All financial news and data tailored to specific country editions
